WHO releases target regimen profiles for long-acting TB injectables
Audio narration · Coming soon
The World Health Organization has released target regimen profiles for long-acting injectable treatments aimed at tuberculosis prevention and therapy. This announcement comes as several long-acting injectable candidates for TB are entering or nearing clinical development, marking a potential advancement in TB treatment options.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews